ABT vs ADBE Stock Comparison
Scores Breakdown
| Metric | ABT | ADBE |
|---|---|---|
| 📈 Growth | 22/30 | 28/30 |
| 💰 Profitability | 17/20 | 18/20 |
| 🏦 Financial Health | 15/20 | 14/20 |
| 💵 Valuation | 12/20 | 14/20 |
| ⚠️ Risk (lower is better) | 4/10 | 6/10 |
| Overall Score | 72/100 | 78/100 |
Side-by-Side Summaries
| ABT Analysis | ADBE Analysis |
|---|---|
📈 Growth & Financial TrajectoryOver the 8-quarter window, Revenue gravitated around $9.96B to $11.16B, ending at $11.16B in 2026 Q1, a start-to-end rise of about $1.2B (~12%). Net income remained positive through most quarters, with modest-to-strong fluctuations; several quarters show mid-single-digit billions in income, with notable variability from one-off items (e.g., tax effects). 💰 Margins & Cash FlowGross Margin was solid, around 56% on average (Gross Profit ~6.3B vs Revenues ~11.2B in 2026 Q1). Operating margin ranged roughly from 12% to 18%, peaking in 2025 Q2. Net cash flow from operating activities was consistently positive (e.g., 2026 Q1: $1.315B; prior quarters in the 1.4–2.9B range), while investing activities were typically cash outflows and financing modest. 🛡️ Balance Sheet & LiquidityTotal assets approximate $72B–$110B over the period with equity in the low-to-mid $50B range. The company shows a healthy current ratio ( ⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryEight quarters show a steady top-line advance from about Revenues of $5.31B to about $6.62B, a roughly 25% gain. Net income remained resilient around $1.7–$1.9B, with modest quarterly swings. The company sustained strong operating margins aided by high gross margin discipline, underscoring durable profitability across periods. 💰 Margins & Cash FlowGross margin stayed in the high-80s, supporting healthy operating income of roughly $2.0–$2.4B on $5.3–$6.6B in Revenues. Net cash flow from operating activities tended positive around $2–3B per quarter, while investing/financing activities produced meaningful outflows, leading to periodic negative overall cash flow. Cash balances ranged ~$5–8B, with a gradual but modest decline as capital deployment evolved. 🛡️ Balance Sheet & LiquidityTotal assets sit near $29–30B with liabilities around $18–18.5B and equity near $11.5B, signaling solid capitalization. The near-term liquidity position shows a tighter profile: current assets ~ $9.0B vs current liabilities ~ $12.0B. Cash reserves provide liquidity, though aggregate cash declined in later quarters due to investing/financing activity. ⚠️ Key Drivers & Risks
|